Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-26-000020
Filing Date
2026-05-06
Accepted
2026-05-06 06:30:51
Documents
74
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20260331.htm   iXBRL 10-Q 1631494
2 EX-31.1 uthrex31103312026.htm EX-31.1 11938
3 EX-31.2 uthrex31203312026.htm EX-31.2 11944
4 EX-32.1 uthrex32103312026.htm EX-32.1 5994
5 EX-32.2 uthrex32203312026.htm EX-32.2 6121
  Complete submission text file 0001082554-26-000020.txt   7948233

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20260331.xsd EX-101.SCH 44106
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20260331_cal.xml EX-101.CAL 72604
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20260331_def.xml EX-101.DEF 234978
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20260331_lab.xml EX-101.LAB 660100
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20260331_pre.xml EX-101.PRE 447756
78 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20260331_htm.xml XML 1231879
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 26945681
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)